» Articles » PMID: 28347910

Acute Lung Injury Complicating Acute Kidney Injury: A Model of Endogenous αKlotho Deficiency and Distant Organ Dysfunction

Overview
Journal Bone
Date 2017 Mar 29
PMID 28347910
Citations 11
Authors
Affiliations
Soon will be listed here.
Abstract

The lung interfaces with atmospheric oxygen via a large surface area and is perfused by the entire venous return bearing waste products collected from the whole body. It is logical that the lung is endowed with generous anti-oxidative capacity derived both locally and from the circulation. The single-pass pleiotropic alpha-Klotho (αKlotho) protein was discovered when its genetic disruption led to premature multi-organ degeneration and early death. The extracellular domain of αKlotho is cleaved by secretases and released into circulation as endocrine soluble αKlotho protein, exerting wide-ranging cytoprotective effects including anti-oxidation on distant organs including the lung, which exhibits high sensitivity to circulating αKlotho insufficiency. Because circulating αKlotho is derived mainly from the kidney, acute kidney injury (AKI) leads to systemic αKlotho deficiency that in turn increases the risks of pulmonary complications, i.e., edema and inflammation, culminating in the acute respiratory distress syndrome. Exogenous αKlotho increases endogenous anti-oxidative capacity partly via activation of the Nrf2 pathway to protect lungs against injury caused by direct hyperoxia exposure or AKI. This article reviews the current knowledge of αKlotho antioxidation in the lung in the setting of AKI as a model of circulating αKlotho deficiency, an under-recognized condition that weakens innate cytoprotective defenses and contributes to the dysfunction in distant organs.

Citing Articles

Preeclampsia as a Study Model for Aging: The Klotho Gene Paradigm.

Cecati M, Fumarola S, Vaiasicca S, Cianfruglia L, Vignini A, Giannubilo S Int J Mol Sci. 2025; 26(3).

PMID: 39940672 PMC: 11817256. DOI: 10.3390/ijms26030902.


Forecasting Acute Kidney Injury and Resource Utilization in ICU patients using longitudinal, multimodal models.

Tan Y, Dede M, Mohanty V, Dou J, Hill H, Bernstam E medRxiv. 2024; .

PMID: 38559064 PMC: 10980131. DOI: 10.1101/2024.03.14.24304230.


The Neglected Price of Pediatric Acute Kidney Injury: Non-renal Implications.

Pande C, Smith M, Soranno D, Gist K, Fuhrman D, Dolan K Front Pediatr. 2022; 10:893993.

PMID: 35844733 PMC: 9279899. DOI: 10.3389/fped.2022.893993.


Klotho and Mesenchymal Stem Cells: A Review on Cell and Gene Therapy for Chronic Kidney Disease and Acute Kidney Disease.

Franco M, Beyerstedt S, Rangel E Pharmaceutics. 2022; 14(1).

PMID: 35056905 PMC: 8778857. DOI: 10.3390/pharmaceutics14010011.


Two to Tango: Kidney-Lung Interaction in Acute Kidney Injury and Acute Respiratory Distress Syndrome.

Alge J, Dolan K, Angelo J, Thadani S, Virk M, Arikan A Front Pediatr. 2021; 9:744110.

PMID: 34733809 PMC: 8559585. DOI: 10.3389/fped.2021.744110.


References
1.
Cullinan S, Zhang D, Hannink M, Arvisais E, Kaufman R, Diehl J . Nrf2 is a direct PERK substrate and effector of PERK-dependent cell survival. Mol Cell Biol. 2003; 23(20):7198-209. PMC: 230321. DOI: 10.1128/MCB.23.20.7198-7209.2003. View

2.
Hu M, Shi M, Cho H, Zhang J, Pavlenco A, Liu S . The erythropoietin receptor is a downstream effector of Klotho-induced cytoprotection. Kidney Int. 2013; 84(3):468-81. PMC: 3758776. DOI: 10.1038/ki.2013.149. View

3.
Brown R, McBurney A, Lunec J, Kelly F . Oxidative damage to DNA in patients with cystic fibrosis. Free Radic Biol Med. 1995; 18(4):801-6. DOI: 10.1016/0891-5849(94)00172-g. View

4.
Blank V . Small Maf proteins in mammalian gene control: mere dimerization partners or dynamic transcriptional regulators?. J Mol Biol. 2008; 376(4):913-25. DOI: 10.1016/j.jmb.2007.11.074. View

5.
Kurundkar A, Thannickal V . Redox mechanisms in age-related lung fibrosis. Redox Biol. 2016; 9:67-76. PMC: 4943089. DOI: 10.1016/j.redox.2016.06.005. View